Rhizen, Pfizer, Dr. Reddy & RDIF might get some relaxation now as Rhizen pharma got the USFDA approval for its clinical trials on the Covid-19 vaccine.
The UK authorizes the Pfizer vaccine for emergency use. Britain marks one of the first countries to start vaccinating its population as it tries to cure Europe’s deadliest Covid-19 outbreak.
Up to date, we were just talking about the prescriptions on drugs for Covid-19 over prevention but now we are happy to say that we can get some relief.
Dr.Reddy and RDIF also commenced their clinical trials for the Sputnik V vaccine in India.
Some Top stocks gained around 300% which makes them marvelous in stock market performance.
It has been like the FII’s ( Foreign Institutional Investment ) had been very bullish in past November sessions.
Aarti Drugs | So far in 2020, this stock gained 394% to Rs 715.35 as of November 27, 2020, from Rs 144.68 on December 31, 2019.
Laurus Labs | So far in 2020, this stock has gained 341% to Rs 317.15 as of November 27, 2020, from Rs 71.91 on December 31, 2019.
Marksans Pharma | So far in 2020, this stock has gained 25% to Rs 58.90 as of November 27, 2020, from Rs 16.71 on December 31, 2019.
Granules India | So far in 2020, this stock has gained 235% to Rs 412.45 as of November 27, 2020, from Rs 123.10 on December 31, 2019.
Navin Fluorine International | So far in 2020, this stock has gained 167% to Rs 2682.70 as of November 27, 2020, from Rs 1006.35 on December 31, 2019.
IG Petrochemicals | So far in 2020, this stock has gained 165% to Rs 445.35 as of November 27, 2020, from Rs 167.80 on December 31, 2019.
I hope this article would have done a help in watching the top FII's gainings of this Year.
